Panacea Biotec Pharma Profile
Key Indicators
- Authorised Capital ₹ 60.00 Cr
- Paid Up Capital ₹ 1.00 M
- Company Age 6 Year, 9 Days
- Last Filing with ROC 31 Mar 2023
- Satisfied Charges ₹ 1,618.44 Cr
- Revenue Growth -46.22%
- Profit Growth -95.54%
- Ebitda -217.12%
- Net Worth 12.60%
- Total Assets -39.59%
About Panacea Biotec Pharma
Panacea Biotec Pharma Limited (PBPL) is a Public Limited Indian Non-Government Company incorporated in India on 22 March 2019 (Six years 9 days old ). Its registered office is in Delhi, India.
The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 60.00 Cr and a paid-up capital of Rs 1.00 M.
The company has closed loans amounting to ₹1,618.44 Cr, and has no open charges as per Ministry of Corporate Affairs (MCA) records.
Rajesh Jain, Narotam Juneja, Ankesh Jain, and One other member serve as directors at the Company.
Company Details
- Location
Delhi, India
- Telephone
+91-XXXXXXXXXX
- Email Address
- Website
- Social Media
Corporate Identity Details
- CIN/LLPIN
U24299DL2019PLC347566
- Company No.
347566
- Company Classification
Public Limited Indian Non-Government Company
- Incorporation Date
22 Mar 2019
- Date of AGM
30 Sep 2023
- Date of Balance Sheet
31 Mar 2023
- Listing Status
Unlisted
- ROC Code
Roc Delhi
Industry
Pharma
Who are the key members and board of directors at Panacea Biotec Pharma?
Executive Team (1)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Rajesh Jain  | Managing Director | 22-Mar-2019 | Current |
Board Members (3)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Manjula Upadhyay | Director | 23-Jul-2021 | Current |
| Narotam Juneja | Whole-Time Director | 01-Apr-2022 | Current |
| Ankesh Jain | Whole-Time Director | 22-Mar-2019 | Current |
Financial Performance of Panacea Biotec Pharma.
Panacea Biotec Pharma Limited, for the financial year ended 2023, experienced significant reduction in revenue, with a 46.22% decrease. The company also saw a substantial fall in profitability, with a 95.54% decrease in profit. The company's net worth Soared by an impressive increase of 12.6%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Panacea Biotec Pharma?
In 2023, Panacea Biotec Pharma had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Dtc India LimitedManjula Upadhyay is a mutual person
The Delhi Flour Mills Company LimitedManjula Upadhyay is a mutual person
- Panacea Biotec Limited
Rajesh Jain, Narotam Juneja and 2 more are mutual person
- Panera Biotec Private Limited
Rajesh Jain is a mutual person
Adveta Power Private LimitedRajesh Jain and Ankesh Jain are mutual person
- Mr Lex Corp Llp
Manjula Upadhyay is a mutual person
Charges (Loans)
Open Charges
₹0
Satisfied Charges
₹1,618.44 Cr
Charges Breakdown by Lending Institutions
- Others : 1618.44 Cr
Latest Charge Details
| Date | Lender | Amount | Status |
|---|---|---|---|
| 01 Feb 2020 | Others | ₹754.44 Cr | Satisfied |
| 06 Apr 2019 | Others | ₹864.00 Cr | Satisfied |
How Many Employees Work at Panacea Biotec Pharma?
Panacea Biotec Pharma has a workforce of 749 employees as of Mar 25, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Panacea Biotec Pharma, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Panacea Biotec Pharma's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
Latest Updates, News, and FAQs on Panacea Biotec Pharma
Recent activity within the organization
- Annual General Meeting
Panacea Biotec Pharma Limited last Annual general meeting of members was held on 30 Sep 2023 as per latest MCA records.
- Balance Sheet
Panacea Biotec Pharma Limited has filed its annual Financial statements for the year ended 31 Mar 2023 with Roc Delhi.
- Director Appointment
Narotam Kumar Juneja was appointed as a Whole-Time Director was appointed as a Whole-Time Director on 01 Apr 2022 & has been associated with this company since 2 years 11 months .
- Charges
A charge registered on 01 Feb 2020 via Charge ID 100332250 with Others was fully satisfied on 03 Mar 2022.
- Charges
A charge with Others of Rs. 754.44 Cr registered on 01 Feb 2020 with Charge ID 100332250 was modified on 16 Nov 2021.
- Director Appointment
Manjula Upadhyay was appointed as a Director was appointed as a Director on 23 Jul 2021 & has been associated with this company since 3 years 8 months .
Recent News, Updates & Announcement
Panacea Biotec partners with Serum Institute of India.Six in one has the potential of over 250 million doses in next 3-4 years with a market size of over $1.25 Billion annually..
- Panacea Biotec files plea against patent for pneumonia vaccine.
India Business News: New Delhi, Dec 27 () Drug firm Panacea Biotec has filed a review petition against the grant of a patent with regard to a pneumonia vaccine to the US-b.
- Panacea Biotec gets USFDA nod to launch Prasugrel tablets.
"The company's first-to-file abbreviated new drug application (ANDA) of Prasugrel 5 mg and 10 mg tablets has been approved by the US Food and Drug Administration (USFDA)," Panacea Biotec said in a BSE filing..
- Panacea Biotec receives manufacturing authorization for 22 medicinal products.
Mumbai: Panacea Biotec said that it has received the Certificate of GMP compliance from State Service of Ukraine on Medicines and Drugs Control with Manufacturing Authorization for 22 medicinal... .
- Panacea Biotec ties up with Canada’s Apotex to launch Prasugrel drug in US | Mint.
Panacea Biotec signs an agreement with Canada's Apotex to launch Prasugrel 5mg and 10mg tablets, used for the treatment of certain coronary diseases, in the US.
Frequently asked questions
What is the Incorporation or founding date of Panacea Biotec Pharma Limited?
Panacea Biotec Pharma Limited was incorporated on 22 Mar 2019.
What is authorized share capital and paid-up capital of Panacea Biotec Pharma Limited?
The authorized share capital of Panacea Biotec Pharma Limited is ₹ 60.00 Cr and paid-up capital is ₹ 1.00 M.
Who are the current board members & directors of Panacea Biotec Pharma Limited?
Currently 4 directors are associated with Panacea Biotec Pharma Limited.
- Rajesh Jain
- Narotam Kumar Juneja
- Ankesh Jain
- Manjula Upadhyay
What is the registered address of Panacea Biotec Pharma Limited?
As per Ministry of Corporate Affairs (Mca), the registered address of Panacea Biotec Pharma Limited is B-1 Extension/A-27 Mohan Co-Operative Industrial Estate, Mathura Road India, New Delhi, 110044.
What is the corporate identification number (CIN) and company number of Panacea Biotec Pharma Limited?
The corporate identification number (CIN) of Panacea Biotec Pharma Limited is U24299DL2019PLC347566 and the company number is 347566 as per Ministry of Corporate Affairs (MCA).
What is the official website of Panacea Biotec Pharma Limited?
The Official website of Panacea Biotec Pharma Limited is https://www.panaceabiotec.com
What has been the recent revenue trend for Panacea Biotec Pharma Limited?
According to the financial reports for the fiscal year 2023, the revenue trend for Panacea Biotec Pharma Limited has fallen by -46.22%.
How many employees does Panacea Biotec Pharma Limited currently have?
As Per 2023 financial reports, 749 employees are currently employed by Panacea Biotec Pharma Limited.
What change has been observed in the net worth of Panacea Biotec Pharma Limited, and by what percentage?
The financial reports for the fiscal year 2023 indicates that The net worth of Panacea Biotec Pharma Limited has experienced an upsurge of 12.60%.
When was the last Balance Sheet of Panacea Biotec Pharma Limited filed with the ROC?
The most recent Balance Sheet for Panacea Biotec Pharma Limited was filed with the ROC on 31 Mar 2023.
People also Viewed
Deepak KanvindeDirectorSA
Sunil AnandDirectorKL
Krishna LalDirectorSN
Shantanu NalavadiNominee DirectorAR
Avinash RamachandraNominee Director